This inventor holds 1 USPTO granted patent. Top assignee: University of Vermont. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: J J McCormack: Innovator in Neoplasm Treatment
Introduction
J J McCormack is a notable inventor based in Burlington, Vermont. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of neoplasms. His innovative work has led to the development of a unique compound that holds promise for cancer therapy.
Latest Patents
J J McCormack holds a patent for "Unsymmetrical 1,4-bis(aminoalkylamino)-anthracene-9,10-diones." This patent describes unsymmetrical compounds that are useful in the treatment of neoplasms. The process involves starting with 1,4-dimethoxyanthracene-9,10-dione, which is reacted with an aminoalkylamine. The resulting product is then treated with a dialkylaminoethylamine or a N-heteroethylamine to yield the unsymmetrical compound.
Career Highlights
J J McCormack is affiliated with the University of Vermont, where he continues to engage in research and development. His work has not only advanced scientific understanding but also contributed to potential therapeutic applications in oncology.
Collaborations
Some of his notable coworkers include John J Landi, Jr and Kenneth J Shaw. Their collaborative efforts have further enriched the research environment at the University of Vermont.
Conclusion
J J McCormack's innovative contributions to the field of medicinal chemistry exemplify the impact of dedicated research on healthcare. His patent for unsymmetrical compounds represents a significant step forward in the treatment of neoplasms.